Roche Holding AGROG:VTX

5.50 / 2.23 %
10.94 %
Close in CHFToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jun 24 2016 16:32 BST.

Consensus recommendation

As of Jun 24, 2016, the consensus forecast amongst 31 polled investment analysts covering Roche Holding Ltd. advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jun 02, 2003. The previous consensus forecast advised investors to hold their position in Roche Holding Ltd..

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
No opinion0

Research Reports

Share price forecast

The 23 analysts offering 12 month price targets for Roche Holding Ltd. have a median target of 300.00, with a high estimate of 385.00 and a low estimate of 247.00. The median estimate represents a 24.48% increase from the last price of 241.00. View Full Financials

High+59.8 %385.00
Med+24.5 %300.00
Low+2.5 %247.00


In 2015, Roche Holding AG reported a dividend of 8.10 CHF, which represents a 1.25% increase over last year. The 25 analysts covering the company expect dividends of 8.57 CHF for the upcoming fiscal year, an increase of 5.84%. View Full Financials

Div growth (TTM)+1.25 %
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Jan 28, 2016, Roche Holding Ltd. reported semi annual 2015 earnings of 6.27 per share. View Full Interim Financials

Average growth rate-4.09 %

Roche Holding Ltd. reported annual 2015 earnings of 13.49 per share on Jan 28, 2016.
The next earnings announcement from Roche Holding Ltd. is expected the week of Oct 20, 2016. View Full Annual Financials

Average growth rate+2.51 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement


Roche Holding AG reported semi annual 2015 revenues of 24.56bn. This missed the 24.67bn consensus estimate of the 6 analysts following the company. This was 0.29% above the prior year's period results. View Full Interim Financials

Average growth rate+1.22 %

Roche Holding AG had revenues for the full year 2015 of 48.15bn. This was 1.44% above the prior year's results. View Full Annual Financials

Average growth rate+3.17 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.